Transforming Cancer Treatment: The Rise of CAR T-Cell Therapy In recent years, Chimeric Antigen Receptor (CAR) T-cell therapy has emerged as a revolutionary approach in the treatment of certain types of cancer. This innovative therapy involves reprogramming a patient's own immune cells to recognize and attack cancer cells, offering new hope where conventional treatments have fallen short. Understanding CAR T-Cell Therapy CAR T-cell therapy harnesses the power of the immune system, particularly T cells, to combat cancer effectively. The process begins by extracting a patient's T cells from their blood. These cells are then genetically engineered in a laboratory to express CARs on their surface. CARs are synthetic receptors that enable T cells to recognize specific antigens present on cancer cells. Download latest CAR-T Market Report @ https://www.delveinsight.com/sample-request/chimeric-antigen-receptor-car-t-cell-therapy-market